Jennifer Good is the founder of Trevi Therapeutics. Trevi Therapeutics has raised $120M in total funding. Based in New Haven, United States.
Jennifer Good is the President and CEO of Trevi Therapeutics, a biotechnology company focused on developing treatments for respiratory diseases, including idiopathic pulmonary fibrosis (IPF). She led the company to raise approximately $120 million after strong data from their IPF cough program. Good is based in New Haven, Connecticut.
Full founder directory · Investor directory · Company funding database · Fundraising library